OraSure To Pay $3M To Settle HIV Test Patent Suit
OraSure revealed the truce Thursday — including a wide-ranging licensing agreement between the parties — which would resolve litigation pending in the U.S. District Court for the District of New Jersey.
Under the deal, OraSure will be granted a worldwide, nonexclusive, royalty-bearing, lateral flow patent license for the OraQuick HIV-1/2 test and other...
Already a subscriber? Click here to login